the role of daratumumab in the treatment of myeloma and insights into the maia trial
Published 1 year ago • 117 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
1:37
daratumumab vs isatuximab in the treatment of multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
1:51
darazadex: a phase ii trial of daratumumab plus azacitidine and dexamethasone in r/r myeloma
-
1:05
an overview of the radar trial
-
13:28
m-power ny | dr. saad usmani presents myeloma treatments: how do we treat myeloma?
-
15:09
subcutaneous daratumumab — dr. jonathan kaufman | mcrt webcast july 11
-
7:32
long-term efficacy of daratumumab-based regimen in multiple myeloma
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:16
mechanism of action & use of daratumumab in multiple myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
2:36
approaching a myeloma population becoming increasingly resistant to daratumumab
-
1:58
treatment options for patients with multiple myeloma who are resistant to daratumumab
-
1:10
how daratumumab will change the treatment of multiple myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
5:36
daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the pollux trial
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
0:54
the experience of single-agent daratumumab for r/r myeloma in india
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma